These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 31307176

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Fecal calprotectin as a promising marker of inflammatory diseases.
    Paduchova Z, Durackova Z.
    Bratisl Lek Listy; 2009; 110(10):598-602. PubMed ID: 20017448
    [Abstract] [Full Text] [Related]

  • 23. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC, Bachmann Holmetoft U, Ingdam Halkjær S, Angeliki Krogfelt K, Munk Petersen A.
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time.
    Amcoff K, Stridsberg M, Lampinen M, Magnuson A, Carlson M, Halfvarson J.
    Scand J Gastroenterol; 2017 Mar; 52(3):344-350. PubMed ID: 27881032
    [Abstract] [Full Text] [Related]

  • 26. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 Mar; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S, Shajib MS, Garvie K, Turner J, Brooks D, Odeh S, Issenman R, Chetty VT, Macri J, Khan WI.
    Can J Gastroenterol Hepatol; 2017 Mar; 2017():1450970. PubMed ID: 28491862
    [Abstract] [Full Text] [Related]

  • 29. Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Julsgaard M, Hvas CL, Gearry RB, Vestergaard T, Fallingborg J, Svenningsen L, Kjeldsen J, Sparrow MP, Wildt S, Kelsen J, Bell SJ.
    Inflamm Bowel Dis; 2017 Jul; 23(7):1240-1246. PubMed ID: 28498159
    [Abstract] [Full Text] [Related]

  • 30. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA, Jonkers D, Janson EA, Stockbrügger RW, Stobberingh EE, Hellström PM, Lundberg JO.
    Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
    [Abstract] [Full Text] [Related]

  • 31. A novel sol particle immunoassay for fecal calprotectin in inflammatory bowel disease patients.
    Okuyama Y, Doi Y, Matsuyama N, Uchino M, Yamamoto T.
    Clin Chim Acta; 2016 May 01; 456():1-6. PubMed ID: 26908083
    [Abstract] [Full Text] [Related]

  • 32. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC, Huang JL, Chang CJ, Kong MS.
    J Pediatr Gastroenterol Nutr; 2012 Nov 01; 55(5):541-7. PubMed ID: 22699836
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J.
    Korean J Gastroenterol; 2016 May 25; 67(5):233-7. PubMed ID: 27206433
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2007 Oct 25; 45(4):414-20. PubMed ID: 18030206
    [Abstract] [Full Text] [Related]

  • 39. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
    Kwapisz L, Mosli M, Chande N, Yan B, Beaton M, Micsko J, Mennill PW, Barnett W, Bax K, Ponich T, Howard J, Tirolese A, Lannigan R, Gregor J.
    Saudi J Gastroenterol; 2015 Oct 25; 21(6):360-6. PubMed ID: 26655130
    [Abstract] [Full Text] [Related]

  • 40. Assessing the Correlation of Fecal Calprotectin and the Clinical Disease Activity Index in Patients With Ulcerative Colitis.
    Amiriani T, Besharat S, Dadjou M, Roshandel G, Mirkarimi H, Salamat F, Joshaghani H.
    Gastroenterol Nurs; 2018 Oct 25; 41(3):201-205. PubMed ID: 29847394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.